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Especially in veterinary medicine, resistance to antimicrobial drugs is most frequently referred to 
bacterial resistance to chemotherapeutics especially antibiotics that we use in order to cure bacterial diseases 
in animals. Usual animal feed antibiotic supplementation, nonselective, uncontrolled and often with no reason 
usage of antibiotic in therapy and prophylaxis are just some of the reasons for such approach to 
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microorganism’s resistance. However, in last few decades development of antiviral drugs is one of the most 
intensive fields of the work of the pharmaceutical industry. One can easily say that there are a few 
unanswered questions as far as viruses that cause disease of mammals are concerned. As a science, virology 
is aware of all aspects of virus biology and infectology. Mechanisms of the virus replication, pathogenic 
pathways in infected hosts and all aspects of virus biology are well known. Moreover, for most of the 
important viruses, whole genetic base has been elucidated. In spite of that, up to now there are not more than 
thirty commercially registered antiviral drugs with a little chance this number to increase. Antiviral repertoire 
most frequently is inhibition of some virus activity such as virus adsorption, fusion with the cell, virus 
uncoating, inhibition of virus enzymes (DNA polymerase, reverse transcriptase, neuraminidase, protease, 
dehydrogenase and hydrolase) as well as virus RNA replication. Apart of the potential importance as a part of 
the therapy in small-luxury veterinary praxis, antivirus drugs are potential hazard if they are used as a part of 
metaphylaxis in order to prevent diseases in the animal species that we use as a food. At the same time there 
is a risk of virus becoming resistant in case of using antiviral drugs in the prophylaxis of the zoonoses.   
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